S, J., M, D., P, C., V, R., Y, F., K, W., . . . JC, H. (2023). Modeling Alzheimer's disease progression utilizing clinical trial and ADNI data to predict longitudinal trajectory of CDR-SB. CPT: pharmacometrics & systems pharmacology, 12(7), 1029. https://doi.org/10.1002/psp4.12974
Chicago Style (17th ed.) CitationS, Jamalian, et al. "Modeling Alzheimer's Disease Progression Utilizing Clinical Trial and ADNI Data to Predict Longitudinal Trajectory of CDR-SB." CPT: Pharmacometrics & Systems Pharmacology 12, no. 7 (2023): 1029. https://doi.org/10.1002/psp4.12974.
MLA (9th ed.) CitationS, Jamalian, et al. "Modeling Alzheimer's Disease Progression Utilizing Clinical Trial and ADNI Data to Predict Longitudinal Trajectory of CDR-SB." CPT: Pharmacometrics & Systems Pharmacology, vol. 12, no. 7, 2023, p. 1029, https://doi.org/10.1002/psp4.12974.